Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-031910

Chief Executive Officer gave up 691 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-22 Shares withheld for taxes : show line 1 in the form −691 $1.45 $1,002 37,188 D
Loading xslF345X04/doc4.xml…